BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26650251)

  • 1. The prevalence of actinic keratosis in patients visiting dermatologists in two hospitals in China.
    Zhao Y; Li CY; Wen CM; Wei YB; Li RY; Wang G; Tu P
    Br J Dermatol; 2016 May; 174(5):1005-10. PubMed ID: 26650251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of actinic keratosis among dermatology outpatients in Austria.
    Eder J; Prillinger K; Korn A; Geroldinger A; Trautinger F
    Br J Dermatol; 2014 Dec; 171(6):1415-21. PubMed ID: 24864059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of actinic keratosis among dermatology outpatients in Spain.
    Ferrándiz C; Plazas MJ; Sabaté M; Palomino R;
    Actas Dermosifiliogr; 2016 Oct; 107(8):674-80. PubMed ID: 27445129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
    Erlendsson AM; Egekvist H; Lorentzen HF; Philipsen PA; Stausbøl-Grøn B; Stender IM; Haedersdal M
    Int J Dermatol; 2016 Mar; 55(3):309-16. PubMed ID: 26276415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis.
    Noels EC; Hollestein LM; van Egmond S; Lugtenberg M; van Nistelrooij LPJ; Bindels PJE; van der Lei J; Stern RS; Nijsten T; Wakkee M
    Br J Dermatol; 2019 Sep; 181(3):544-553. PubMed ID: 30636037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variation in the Cost of Managing Actinic Keratosis.
    Kirby JS; Gregory T; Liu G; Leslie DL; Miller JJ
    JAMA Dermatol; 2017 Apr; 153(4):264-269. PubMed ID: 28249074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of actinic keratosis in patients attending the dermatology outpatient clinic.
    Yaldiz M
    Medicine (Baltimore); 2019 Jul; 98(28):e16465. PubMed ID: 31305480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the management of actinic keratosis: a qualitative interview study among general practitioners and dermatologists.
    Noels EC; Lugtenberg M; van Egmond S; Droger SM; Buis PAJ; Nijsten T; Wakkee M
    Br J Dermatol; 2019 Jul; 181(1):96-104. PubMed ID: 30801664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of actinic keratoses in Germany--analysis of multisource data.
    Schaefer I; Augustin M; Spehr C; Reusch M; Kornek T
    J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):309-13. PubMed ID: 23347271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physicians' opinions and clinical practice patterns for actinic keratosis management in Italy.
    Peris K; Neri L; Calzavara Pinton P; Catricalà C; Pellacani G; Pimpinelli N; Peserico A
    G Ital Dermatol Venereol; 2014 Apr; 149(2):185-92. PubMed ID: 24819638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in precision of counting actinic keratoses.
    Lee KC; Lew R; Weinstock MA
    Br J Dermatol; 2014 Jan; 170(1):188-91. PubMed ID: 24102420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study.
    Flohil SC; van der Leest RJ; Dowlatshahi EA; Hofman A; de Vries E; Nijsten T
    J Invest Dermatol; 2013 Aug; 133(8):1971-8. PubMed ID: 23510990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Actinic Keratosis in Patients Attending General Practitioners in Switzerland.
    Dziunycz PJ; Schuller E; Hofbauer GFL
    Dermatology; 2018; 234(5-6):214-219. PubMed ID: 30125890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal cell carcinomas and actinic keratoses seen in dermatological practice in France: a cross-sectional survey.
    Bernard P; Dupuy A; Sasco A; Brun P; Duru G; Nicoloyannis N; Grob JJ
    Dermatology; 2008; 216(3):194-9. PubMed ID: 18182809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and awareness of actinic keratosis: barriers and opportunities.
    Rosen T; Lebwohl MG
    J Am Acad Dermatol; 2013 Jan; 68(1 Suppl 1):S2-9. PubMed ID: 23228302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A survey of office visits for actinic keratosis as reported by NAMCS, 1990-1999. National Ambulatory Medical Care Survey.
    Gupta AK; Cooper EA; Feldman SR; Fleischer AB
    Cutis; 2002 Aug; 70(2 Suppl):8-13. PubMed ID: 12353680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of actinic keratoses.
    Green AC
    Curr Probl Dermatol; 2015; 46():1-7. PubMed ID: 25561199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics.
    Fargnoli MC; Altomare G; Benati E; Borgia F; Broganelli P; Carbone A; Chimenti S; Donato S; Girolomoni G; Micali G; Moggio E; Parodi A; Piaserico S; Pistone G; Potenza C; Puviani M; Raucci M; Vaccari S; Veglio S; Zanca A; Peris K
    Eur J Dermatol; 2017 Dec; 27(6):599-608. PubMed ID: 29311040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.